Kraj: Irlandia
Język: angielski
Źródło: HPRA (Health Products Regulatory Authority)
OXYMETAZOLINE HYDROCHLORIDE
Procter & Gamble (Health & Beauty Care) Limited
R01AA05
OXYMETAZOLINE HYDROCHLORIDE
0.05 %w/v
Nasal Spray Solution
Product not subject to medical prescription
oxymetazoline
Marketed
1998-07-13
1. WHAT VICKS SINEX MICROMIST IS AND WHAT IT IS USED FOR Vicks Sinex Micromist is a nasal spray used for localised relief of the symptoms of a blocked nose in association with a cold, hay fever or sinusitis (infl ammation of the passages leading to the nose). The effect of the spray starts after several minutes and lasts for 6-8 hours. The active substance is oxymetazoline hydrochloride. 2. BEFORE YOU USE VICKS SINEX MICROMIST DO NOT USE VICKS SINEX MICROMIST IF YOU: • are allergic (hypersensitive) to the active substance oxymetazoline hydrochloride or any of the other ingredients of Vicks Sinex Micromist (see section 6) • have infl amed skin or mucous membranes of your nostrils or have scabs in your nose. DO NOT GIVE VICKS SINEX MICROMIST TO CHILDREN UNDER 12 YEARS OF AGE TAKE SPECIAL CARE WITH VICKS SINEX MICROMIST Before using tell your doctor if you have: • diffi culty urinating due to an enlarged prostate gland • high blood pressure • heart disease including angina • diabetes • disturbance in your thyroid function • hepatic or renal disorder • suffer from increased eyeball-pressure (narrow-angle glaucoma) TAKING OTHER MEDICINES Please inform your doctor or pharmacist if you are taking, or have recently taken, any other medicines, even those obtained without a prescription. • MONOAMINE OXIDASE INHIBITORS (MAOIs) are used in the treatment of Parkinson’s disease and depression - DO NOT USE Vicks Sinex Micromist if you have taken MAOIs during the last two weeks • PHENOTHIAZINES AND TRICYCLIC ANTIDEPRESSANTS - inform your doctor if you are taking drugs used in the treatment of depression such as amitriptyline and imipramine • HIGH BLOOD PRESSURE MEDICINES - inform your doctor before use if you are taking digoxin, beta blockers or any other drugs for lowering blood pressure • PARKINSON’S DISEASE MEDICINE (SUCH AS BROMOCRIPTINE) - treatment with Vicks Sinex Micromist may be affected if it is used at the same time. • DO NOT TAKE with other medications containing decongestants PREGNANC Przeczytaj cały dokument
SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE MEDICINAL PRODUCT Vicks Sinex Micromist 0.05% w/v Nasal Spray, Solution 2 QUALITATIVE AND QUANTITATIVE COMPOSITION For a full list of excipients, see section 6.1. 3 PHARMACEUTICAL FORM Nasal Spray, Solution (Nasal Spray) Non-pressurised, metered dose, aqueous nasal spray solution. Solution is a clear liquid with a slight yellowish colouration. 4 CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS The symptomatic relief of acute rhinitis in allergic or upper respiratory tract infection, including the common cold or influenza. 4.2 POSOLOGY AND METHOD OF ADMINISTRATION Topical application as a nasal spray. Adults and children over 12 years: 1-2 sprays per nostril every 6-8 hours unless otherwise advised by your doctor. Not to be used for children under 12 years of age. 4.3 CONTRAINDICATIONS Hypersensitivity to oxymetazoline or any of the other ingredients. Where there is inflammation or lesions of the skin around the nostrils or nasal mucosa. Not to be used for children under 12 years of age. 4.4 SPECIAL WARNINGS AND PRECAUTIONS FOR USE Patients are advised to consult their doctor before taking this medicine if they: Have high blood pressure, heart disease including angina, diabetes, thyroid disease, hepatic or renal disorders. Are currently taking (or have taken during the last two weeks) monoamine oxidase inhibitors (MAOIs). Have narrow angle glaucoma. Active ingredient: % w/v Oxymetazoline hydrochloride 0.05 Excipients: % w/v Benzalkonium chloride solution (50%) 0.04 H E A L T H P R O D U C T S R E G U L A T O R Y A U T H O R I T Y ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ Przeczytaj cały dokument